Cafepharma Today

June 12 2025 - BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
Medtronic recalls ventilators linked to 2 serious injuries, 1 death
Merck aims to plug dengue fever vaccine gap in US
RFK Jr. names some vaccine critics to key CDC committee after ousting entire panel
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Will 3 Versions of Pfizer Be More Valuable Than 1?
Motley Fool
Wednesday, September 25, 2013 - 3:16pm
tags:
Pfizer, spinoffs, Zoetis
Pacific Biosciences Rockets on Roche Diagnostics Deal
Motley Fool
Wednesday, September 25, 2013 - 1:11pm
tags:
Roche, diagnostics, Pacific Biosciences
FierceBiotech's 2013 Fierce 15
Fierce Biotech
Wednesday, September 25, 2013 - 1:04pm
tags:
biotech, AnaptysBio, Acetylon Pharmaceuticals, CytomX, Immunocore, FibroGen, Jounce Therapeutics, Kala Pharmaceuticals, Macrogenics, Moderna Therapeutics, Presage Biosciences, Nimbus Discovery, Scioderm, Ultragenyx, uniQure, Visterra
A Closer Look at 4 Pharmaceutical Giants
Motley Fool
Wednesday, September 25, 2013 - 11:02am
tags:
Merck, Pfizer, JNJ, GSK
Infinity Pharma's cancer drug fails mid-stage trial goals
Reuters
Wednesday, September 25, 2013 - 10:41am
tags:
Infinity Pharma, non-small cell lung cancer, retaspimycin
Novo Nordisk And A Questionable Form Of Victoza Promotion?
Pharmalot
Wednesday, September 25, 2013 - 10:35am
tags:
Novo Nordisk, Victoza, diabetes
Mylan being sued by Forest Labs over generic version of Savella
The Fly on the Wall
Wednesday, September 25, 2013 - 10:34am
tags:
Mylan, Forest Labs, generics, Savella
Oncothyreon is a potential target of Merck KGaA, says Cowen
Yahoo/Fly on the Wall
Wednesday, September 25, 2013 - 10:33am
tags:
M&A, Oncothyreon, Merck KGaA
Government shutdown would likely roil FDA's drug-approval process
Fierce Biotech
Wednesday, September 25, 2013 - 9:34am
tags:
drug approvals, FDA
Ophthotech, Foundation Medicine loot booming biotech IPO market for $273M
Fierce Biotech
Wednesday, September 25, 2013 - 9:29am
tags:
Ophthotech, IPOs, Foundation Medicine
Amarin says Vascepa study surpassed 6,000 patients
Yahoo/Fly on the Wall
Wednesday, September 25, 2013 - 9:25am
tags:
Amarin, Vascepa, clinical trials
Making The Call: Onconova MDS Drug Study Will Succeed
TheStreet.com
Wednesday, September 25, 2013 - 9:21am
tags:
Onconova, MDS, Rigosertib, Celgene
Johnson & Johnson, Cardinal Health Win Pentagon Contracts
Motley Fool
Wednesday, September 25, 2013 - 9:14am
tags:
Cardinal Health, JNJ, government contracts
Stryker to buy Mako Surgical for $1.65 billion
Reuters
Wednesday, September 25, 2013 - 9:06am
tags:
devices, M&A, Mako Surgical, Stryker
OncoMed granted additional broad anti-RSPO antibody patent in U.S.
Yahoo/Fly on the Wall
Wednesday, September 25, 2013 - 9:03am
tags:
OncoMed, anti-RSPO, patents, antibodies
Pfizer rolls out digital reps in U.K., hoping for access to primary-care docs
Fierce Pharma
Wednesday, September 25, 2013 - 8:48am
tags:
UK, physicians, Pfizer, e-detailing, drug reps
Neostem: A Multi-Faceted Stem Cell Sector Play
Seeking Alpha
Wednesday, September 25, 2013 - 8:46am
tags:
NeoStem, stem cells, AMR-101, Athelos Platform
Merck KGaA to continue testing cancer vaccine
Reuters
Wednesday, September 25, 2013 - 8:44am
tags:
vaccines, Merck KGaA, Stimuvax, Oncothyreon, non-small cell lung cancer
Medical-Device Makers See EU Rules Slowing U.S. Approvals
Bloomberg
Wednesday, September 25, 2013 - 8:43am
tags:
devices, Europe
Lilly Bets Quality Will Pay Off in U.S. Diabetes Battle
Bloomberg
Wednesday, September 25, 2013 - 8:41am
tags:
Eli Lilly, diabetes, Novo Nordisk, Bristol-Myers Squibb, Merck

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.